DHL获得了Cryoport的生物制药航运服务,以提升其全球生命科学物流。 DHL acquires Cryoport's biopharma shipping service to boost its global life sciences logistics.

DHL集团已获得Cryoport的CRYOPDP(CRYOPDP),这是临床试验和生物制药的特长信使,以扩大其生命科学物流。 DHL Group has acquired Cryoport's CRYOPDP, a specialty courier for clinical trials and biopharma, to expand its life sciences logistics. 这项交易在有待监管批准之前,包括一个伙伴关系,以加强全球供应链服务。 The deal, pending regulatory approval, includes a partnership to enhance supply chain services globally. CRYOPDP每年处理600,000多批货运,为135个国家提供服务。 CRYOPDP handles over 600,000 shipments annually, serving 135 countries. 此举支持DHL2030战略,旨在加强其在高价值先进制药部门的地位。 This move supports DHL’s Strategy 2030, aiming to strengthen its position in the high-value advanced pharma sector.